Ahmad S, Hatch M
Nephron. 1985;41(3):235-40. doi: 10.1159/000183589.
Measurement of oxalate levels in 14 patients with chronic renal failure, treated by maintenance hemodialysis, revealed elevated plasma oxalate concentrations in all patients 1,075.7 +/- (SEM) 253 micrograms/dl. In 7 of these subjects the oxalate concentration was more than three times higher than the upper limit of normal. Furthermore, a strong positive correlation (r = 0.75) between serum creatinine and plasma oxalate concentration was found. A combination of hemodialysis and hemoperfusion procedure was carried out in a dialysis patient with primary oxalosis as a cause of renal failure. The average oxalate clearance of the hemodialyzer during seven hemodialysis/hemoperfusion procedures was 91 ml/min and that of the charcoal detoxifier was 24 ml/min. The amount of oxalate removed during 4 1/2 h of the hemodialysis/hemoperfusion procedure was 429 mg. This amount was calculated to be produced in about 87 h, with an oxalate generation rate of 4.9 mg/h.
对14例接受维持性血液透析治疗的慢性肾衰竭患者的草酸盐水平进行测量,结果显示所有患者的血浆草酸盐浓度均升高,为1,075.7±(标准误)253微克/分升。在这些受试者中,有7人的草酸盐浓度比正常上限高出三倍以上。此外,还发现血清肌酐与血浆草酸盐浓度之间存在强正相关(r = 0.75)。对一名因原发性草酸盐增多症导致肾衰竭的透析患者进行了血液透析和血液灌流联合治疗。在七次血液透析/血液灌流治疗过程中,血液透析器的平均草酸盐清除率为91毫升/分钟,活性炭解毒器的平均草酸盐清除率为24毫升/分钟。在4.5小时的血液透析/血液灌流治疗过程中清除的草酸盐量为429毫克。该量经计算约在87小时内产生,草酸盐生成率为4.9毫克/小时。